Antidepressant Drugmaker Seaport Seeks $212.4 Million in US IPO
✨ AI Summary
🔊 جاري الاستماع
Seaport Therapeutics Inc., a clinical-stage biotechnology company focused on antidepressants and anxiety drugs, is seeking to raise $212.4 million in a US initial public offering.
